News

In this episode, Renata Block, DMSCc, MMS, PA-C, discusses the new ICD-10 code for topical steroid withdrawal with Kelly Barta, the president and executive director of the International Topical Steroid Awareness Network.

New trends around cheeky swimwear and tanning myths are leading to rising rates of melanomas in sensitive areas; read July's cover story to learn more.

Long-term TNF inhibitor use was associated with significantly increased risks of melanoma and nonmelanoma skin cancer in a large cohort study.

This review of the latest dermatological studies includes insights on the burden of flooding, finasteride versus dutasteride in AGA, myocardial dysfunction in psoriasis patients, and more.

Dermatologists and oncologists at a Dermatology Times Evolving Paradigms event in Boston compared immunotherapy selection, referral practices and surveillance strategies in advanced cutaneous squamous cell carcinoma.

Derm Dispatch host Renata Block, DMSCc, MMS, PA-C, and Kelly Barta, president and executive director of the International Topical Steroid Awareness Network, discuss the new ICD-10 code for topical steroid withdrawal and ITSAN's international patient registry.

European task force review finds dermatology and AI skin cancer apps booming in Europe, but clinical proof, CE marking, and GDPR transparency lag.

Real-world TARGET-DERM data show switching to upadacitinib boosts skin clearance, itch relief and quality of life for tough atopic dermatitis.

NPF guidance outlines patient selection, counseling, and multidisciplinary management of GLP-1 receptor agonists in psoriasis.

IEC modified Delphi process establishes standardized treatment targets for atopic dermatitis

New research shows bakuchiol ferulate mimics retinol’s skin-renewal effects while boosting light and heat stability, lowering phototoxicity, and improving irritation tolerance in tests.

In a recent study, low-fluence fractional 694‑nm ruby laser safely lightened stubborn melasma, while AI imaging tracked subtle pigment and texture improvements missed clinically.

A JAMA Dermatology study found expert dermatologists achieved the highest multiclass diagnostic accuracy when tested against AI across a realistic spectrum of skin lesions.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.

Christopher Bunick, MD, PhD, discussed new data suggesting emergency departments continue to rely on outdated therapies for pediatric atopic dermatitis flares despite evolving dermatology guidelines.

Do patients really need to stop using retinoids in the summer or is that just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.

Dermatologists and oncologists at a Dermatology Times Evolving Paradigms event in Dallas compared immunotherapy selection, adverse event management, and referral practices in advanced cutaneous squamous cell carcinoma.

Placebo-arm RCTs show gentle cleansing, moisturizing, and sunscreen alone can significantly improve acne, rosacea, AKs, melasma, and PIH, boosting outcomes beyond prescriptions.

Konika Patel Schallen, MD, discussed how nanofractional laser treatments may support regenerative skin health beyond cosmetic improvement and outlined the next research priorities in a recent Dermatology Times interview

Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.

New phase 3 data presented at the AAD Innovation Academy show zasocitinib achieved high rates of clear or almost clear skin at the scalp, palms, soles, and nails at week 16.

Anatomy-guided VectorLift thread lift cuts pain and downtime, lowers bruising risk, and delivers comparable facial lifting in real-world patient study.

Konika Patel Schallen, MD, senior vice president and medical director of global clinical operations at Candela Medical, discussed epigenetic changes linked to laser skin resurfacing in a recent Dermatology Times interview.

Christopher Bunick, MD, PhD, discussed the scientific advances still needed before precision medicine can guide individualized therapy selection in atopic dermatitis during a recent Dermatology Times interview.

Kathleen Suozzi, MD, details how she debunks sunscreen myths, explains absorption and SPF, urges year‑round UV habits, and previews new filter bemotrizinol, when counseling her own patients.

New phase 3 data show oral TYK2 inhibitor soficitinib improves moderate-to-severe atopic dermatitis, easing itch with no new safety signals.

Extended-release oral minoxidil candidate VDPHL01 improved hair counts and patient-reported outcomes in women with pattern hair loss in a phase 2 study.

This review of the latest dermatological studies includes insights on gut dysbiosis in inflammatory conditions, air pollution and vitiligo risk, emollient use in AD patients, and more.

Peter Lio, MD, discussed how stress, sleep disruption, and patient-centered communication can influence pediatric atopic dermatitis management during a recent Skin and Psych podcast interview.

New JCI research identifies succinate/SUCNR1 signaling as a potential mechanistic link between hyperglycemia and worsening vitiligo.